Early Administration Actions in 2025

Since taking office, President Trump has issued eighty-plus executive orders (EOs) which are listed on the White House presidential actions webpage. We expect some of these activities to directly impact HTCs and the hemophilia grant programs that provide them with funding.

We have prepared a summary of the President’s EOs pertaining to reducing diversity, equity, and inclusion policies and preferences in government programs. The President planned to freeze federal funding of certain federal programs that were on a list issued by the US Office of Management and Budget. This freeze was rescinded, but the Administration intends to continue the review of programs on the list. The HRSA and CDC Hemophilia programs are on this list.

HTCs with negotiated indirect cost rates with the federal government could be impacted by new guidance from NIH that caps indirect costs charged to NIH at no more than 15%. A federal judge used a temporary restraining order to halt this move for now. However, if an HTC has a negotiated indirect cost rate, you may wish to inquire whether the NIH policy could be applied to your CDC and HRSA grant indirect cost rate too, if this policy were to be reinstated.